PRICE T ROWE ASSOCIATES INC 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Sale | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | PRICE T ROWE ASSOCIATES INC | 21,972 0.500% | -404,722 (-94.85%) | Filing |
| 2024-02-14 10:03 am Sale | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | PRICE T ROWE ASSOCIATES INC | 426,694 9.900% | -17,864 (-4.02%) | Filing |
| 2023-06-12 2:10 pm Purchase | 2023-05-31 | 13G | RAPT Therapeutics, Inc. RAPT | PRICE T ROWE ASSOCIATES INC | 444,558 10.400% | 23,947 (+5.69%) | Filing |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | PRICE T ROWE ASSOCIATES INC | 420,611 9.900% | -72,850 (-14.76%) | Filing |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | PRICE T ROWE ASSOCIATES INC | 493,461 13.300% | 170,275 (+52.69%) | Filing |
| 2021-02-16 12:24 pm Sale | 2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | PRICE T ROWE ASSOCIATES INC | 323,186 10.500% | -5,317 (-1.62%) | Filing |